168 related articles for article (PubMed ID: 31652569)
1. WIN55,212-2-Induced Expression of Mir-29b1 Favours the Suppression of Osteosarcoma Cell Migration in a SPARC-Independent Manner.
Notaro A; Emanuele S; Geraci F; D'Anneo A; Lauricella M; Calvaruso G; Giuliano M
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31652569
[TBL] [Abstract][Full Text] [Related]
2. The secreted protein acidic and rich in cysteine is a critical mediator of cell death program induced by WIN/TRAIL combined treatment in osteosarcoma cells.
Notaro A; Sabella S; Pellerito O; Vento R; Calvaruso G; Giuliano M
Int J Oncol; 2016 Mar; 48(3):1039-44. PubMed ID: 26698404
[TBL] [Abstract][Full Text] [Related]
3. [Cannabinoid WIN55, 212-2 inhibits proliferation, invasion and migration of human SMMC-7721 hepatocellular carcinoma cells].
Wang J; Deng Y; Tan Y; Li K; Wen B; Zhao Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 May; 32(5):619-24. PubMed ID: 27126940
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells.
Xu D; Wang J; Zhou Z; He Z; Zhao Q
Mol Med Rep; 2015 Dec; 12(6):7963-70. PubMed ID: 26500101
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of autophagy and enhancement of endoplasmic reticulum stress increase sensitivity of osteosarcoma Saos-2 cells to cannabinoid receptor agonist WIN55,212-2.
Zhang G; Bi H; Gao J; Lu X; Zheng Y
Cell Biochem Funct; 2016 Jul; 34(5):351-8. PubMed ID: 27309350
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid WIN 55,212-2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid-receptor 2 dependent manner.
Roberto D; Klotz LH; Venkateswaran V
Prostate; 2019 Feb; 79(2):151-159. PubMed ID: 30242861
[TBL] [Abstract][Full Text] [Related]
7. Involvement of PAR-4 in cannabinoid-dependent sensitization of osteosarcoma cells to TRAIL-induced apoptosis.
Notaro A; Sabella S; Pellerito O; Di Fiore R; De Blasio A; Vento R; Calvaruso G; Giuliano M
Int J Biol Sci; 2014; 10(5):466-78. PubMed ID: 24795528
[TBL] [Abstract][Full Text] [Related]
8. PPARγ mediates the effects of WIN55,212-2, an synthetic cannabinoid, on the proliferation and apoptosis of the BEL-7402 hepatocarcinoma cells.
Hong Y; Zhou Y; Wang Y; Xiao S; Liao DJ; Zhao Q
Mol Biol Rep; 2013 Nov; 40(11):6287-93. PubMed ID: 24062073
[TBL] [Abstract][Full Text] [Related]
9. The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro.
Luca T; Di Benedetto G; Scuderi MR; Palumbo M; Clementi S; Bernardini R; Cantarella G
Eur J Pharmacol; 2009 Aug; 616(1-3):16-21. PubMed ID: 19539619
[TBL] [Abstract][Full Text] [Related]
10. The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cells.
Sreevalsan S; Safe S
Mol Cancer Ther; 2013 Nov; 12(11):2483-93. PubMed ID: 24030632
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid WIN 55,212-2 Inhibits Human Glioma Cell Growth by Triggering ROS-Mediated Signal Pathways.
Wang K; Wang Q; Li Q; Zhang Z; Gao J; Fan C; Sun B; Ni Q
Biomed Res Int; 2021; 2021():6612592. PubMed ID: 33977107
[TBL] [Abstract][Full Text] [Related]
12. WIN induces apoptotic cell death in human colon cancer cells through a block of autophagic flux dependent on PPARγ down-regulation.
Pellerito O; Notaro A; Sabella S; De Blasio A; Vento R; Calvaruso G; Giuliano M
Apoptosis; 2014 Jun; 19(6):1029-42. PubMed ID: 24696378
[TBL] [Abstract][Full Text] [Related]
13. The synthetic cannabinoid R(+)WIN 55,212-2 inhibits the interleukin-1 signaling pathway in human astrocytes in a cannabinoid receptor-independent manner.
Curran NM; Griffin BD; O'Toole D; Brady KJ; Fitzgerald SN; Moynagh PN
J Biol Chem; 2005 Oct; 280(43):35797-806. PubMed ID: 16105834
[TBL] [Abstract][Full Text] [Related]
14. WIN55,212-2 induces caspase-independent apoptosis on human glioblastoma cells by regulating HSP70, p53 and Cathepsin D.
Silva AG; Lopes CFB; Carvalho Júnior CG; Thomé RG; Dos Santos HB; Reis R; Ribeiro RIMA
Toxicol In Vitro; 2019 Jun; 57():233-243. PubMed ID: 30776504
[TBL] [Abstract][Full Text] [Related]
15. miR-33a Mediates the Anti-Tumor Effect of Lovastatin in Osteosarcoma by Targeting CYR61.
Huang Y; Zhang J; Shao H; Liu J; Jin M; Chen J; Zhao H
Cell Physiol Biochem; 2018; 51(2):938-948. PubMed ID: 30466075
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the CB
Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
[TBL] [Abstract][Full Text] [Related]
17. WIN 55,212-2 Inhibits the Epithelial Mesenchymal Transition of Gastric Cancer Cells via COX-2 Signals.
Xian X; Huang L; Zhang B; Wu C; Cui J; Wang Z
Cell Physiol Biochem; 2016; 39(6):2149-2157. PubMed ID: 27802436
[TBL] [Abstract][Full Text] [Related]
18. miR-let-7f-1 regulates SPARC mediated cisplatin resistance in medulloblastoma cells.
Pannuru P; Dontula R; Khan AA; Herbert E; Ozer H; Chetty C; Lakka SS
Cell Signal; 2014 Oct; 26(10):2193-201. PubMed ID: 25014664
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of interleukin-1β-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2.
Scholl A; Ivanov I; Hinz B
Oncotarget; 2016 Sep; 7(38):61438-61457. PubMed ID: 27556861
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptor agonist as an alternative drug in 5-fluorouracil-resistant gastric cancer cells.
Xian XS; Park H; Choi MG; Park JM
Anticancer Res; 2013 Jun; 33(6):2541-7. PubMed ID: 23749906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
